Background Urinary tract infection (UTI) is a common infection that poses a substantial healthcare burden, yet its definitive diagnosis can be challenging. There is a need for a rapid, sensitive and reliable analytical method that could allow early detection of UTI and reduce unnecessary antibiotics. Pathogen identification along with quantitative detection of lactoferrin, a measure of pyuria, may provide useful information towards the overall diagnosis of UTI. Here, we report an integrated biosensor platform capable of simultaneous pathogen identification and detection of urinary biomarker that could aid the effectiveness of the treatment and clinical management. Methodology/Principal Findings The integrated pathogen 16S rRNA and host lactoferrin detection using the biosensor array was performed on 113 clinical urine samples collected from patients at risk for complicated UTI. For pathogen detection, the biosensor used sandwich hybridization of capture and detector oligonucleotides to the target analyte, bacterial 16S rRNA. For detection of the protein biomarker, the biosensor used an analogous electrochemical sandwich assay based on capture and detector antibodies. For this assay, a set of oligonucleotide probes optimized for hybridization at 37°C to facilitate integration with the immunoassay was developed. This probe set targeted common uropathogens including E. coli, P. mirabilis, P. aeruginosa and Enterococcus spp. as well as less common uropathogens including Serratia, Providencia, Morganella and Staphylococcus spp. The biosensor assay for pathogen detection had a specificity of 97% and a sensitivity of 89%. A significant correlation was found between LTF concentration measured by the biosensor and WBC and leukocyte esterase (p<0.001 for both). Conclusion/Significance We successfully demonstrate simultaneous detection of nucleic acid and host immune marker on a single biosensor array in clinical samples. This platform can be used for multiplexed detection of nucleic acid and protein as the next generation of urinary tract infection diagnostics.
References
[1]
Esclarin De Ruz A, Garcia Leoni E, Herruzo Cabrera R (2000) Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol 164: 1285–1289.
[2]
Nanda N, Juthani-Mehta M (2009) Novel biomarkers for the diagnosis of urinary tract infection-a systematic review. Biomark Insights 4: 111–121.
[3]
Lazcka O, Del Campo FJ, Munoz FX (2007) Pathogen detection: a perspective of traditional methods and biosensors. Biosens Bioelectron 22: 1205–1217.
[4]
Nayak M, Kotian A, Marathe S, Chakravortty D (2009) Detection of microorganisms using biosensors-a smarter way towards detection techniques. Biosens Bioelectron 25: 661–667.
[5]
Liao JC, Mastali M, Gau V, Suchard MA, Moller AK, et al. (2006) Use of electrochemical DNA biosensors for rapid molecular identification of uropathogens in clinical urine specimens. J Clin Microbiol 44: 561–570.
[6]
Liao JC, Mastali M, Li Y, Gau V, Suchard MA, et al. (2007) Development of an advanced electrochemical DNA biosensor for bacterial pathogen detection. J Mol Diagn 9: 158–168.
[7]
Mach KE, Du CB, Phull H, Haake DA, Shih MC, et al. (2009) Multiplex pathogen identification for polymicrobial urinary tract infections using biosensor technology: a prospective clinical study. J Urol 182: 2735–2741.
[8]
Pan Y, Sonn GA, Sin ML, Mach KE, Shih MC, et al. (2010) Electrochemical immunosensor detection of urinary lactoferrin in clinical samples for urinary tract infection diagnosis. Biosens Bioelectron 26: 649–654.
[9]
Mastali M, Babbitt JT, Li Y, Landaw EM, Gau V, et al. (2008) Optimal probe length and target location for electrochemical detection of selected uropathogens at ambient temperature. J Clin Microbiol 46: 2707–2716.
[10]
Ashelford KE, Weightman AJ, Fry JC (2002) PRIMROSE: a computer program for generating and estimating the phylogenetic range of 16S rRNA oligonucleotide probes and primers in conjunction with the RDP-II database. Nucleic Acids Res 30: 3481–3489.
[11]
Cole JR, Wang Q, Cardenas E, Fish J, Chai B, et al. (2009) The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 37: D141–D145.
[12]
Drummond AJ, Ashton B, Cheung M, Heled J, Kearse , et al. (2009) Geneious v4.7, Available from http://www.geneious.com/.
[13]
Bremer H, Dennis PP (1987) Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology. pp. 1527–1542. American Society for Microbiology, Washington, DC.
[14]
Neidhardt FC, Umbarger HE (1996) Chemical composition of Escherichia coli. In: Neidhardt F, editor. Escherichia coli and Salmonella typhimurium. 2nd ed. pp. 13_–16. ASM Press: Washington, DC Vol. I.
[15]
Pieretti B, Brunati P, Pini B, Colzani C, Congedo P, et al. (2010) Diagnosis of bacteriuria and leukocyturia by automated flow cytometry compared with urine culture. Journal of clinical microbiology 48: 3990–3996.
[16]
Jolkkonen S, Paattiniemi EL, Karpanoja P, Sarkkinen H (2010) Screening of urine samples by flow cytometry reduces the need for culture. J Clin Microbiol 48: 3117–3121.
[17]
Manoni F, Fornasiero L, Ercolin M, Tinello A, Ferrian M, et al. (2009) Cutoff values for bacteria and leukocytes for urine flow cytometer Sysmex UF-1000i in urinary tract infections. Diagnostic microbiology and infectious disease 65: 103–107.
[18]
Sin ML, Gao J, Liao JC, Wong P (2011) System Integration - A Major Step toward Lab on a Chip. Journal of Biological Engineering 5: 6.
[19]
Mariella R Jr (2008) Sample preparation: the weak link in microfluidics-based biodetection. Biomed Microdevices 10: 777–784.
[20]
Chi EY, Krishnan S, Randolph TW, Carpenter JF (2003) Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm Res 20: 1325–1336.
[21]
Mach KE, Mohan R, Baron EJ, Shih MC, Gau V, et al. (2011) A biosensor platform for rapid antimicrobial susceptibility testing directly from clinical samples. J Urology 185: 148–153.
[22]
Arao S, Matsuura S, Nonomura M, Miki K, Kabasawa K, et al. (1999) Measurement of urinary lactoferrin as a marker of urinary tract infection. J Clin Microbiol 37: 553–557.
[23]
Cardenas DD, Hooton TM (1995) Urinary tract infection in persons with spinal cord injury. Arch Phys Med Rehabil 76: 272–280.
[24]
Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, et al. (2010) Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 50: 625–663.
[25]
Mach KE, Wong PK, Liao JC (2011) Biosensor diagnosis of urinary tract infections: a path to better treatment? Trends Pharmacol Sci 32: 330–336.
[26]
Gao J, Sin ML, Liu T, Gau V, Liao JC, et al. (2011) Hybrid electrokinetic manipulation in high-conductivity media. Lab Chip 11: 1770–1775.
[27]
Summanen PH, Durmaz B, Vaisanen ML, Liu C, Molitoris D, et al. (2005) Porphyromonas somerae sp. nov., a pathogen isolated from humans and distinct from Porphyromonas levii. J Clin Microbiol 43: 4455–4459.
